Owkin and Amgen announced results of a three-year project leveraging artificial intelligence to more accurately predict cardiovascular risk. This study demonstrates the ability of AI to improve the way clinicians predict patients’ risk of suffering major cardiovascular events, such as strokes and myocardial infarctions.   Using data from 13,756 patients who were part of FOURIER, a large Amgen clinical trial, Owkin trained a machine-learning algorithm to predict those at higher risk of ca...